Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MREO
4926
CALL
Mereo BioPharma
MREO
$60.7M
| $2.33K | ﹤0.01% |
5,600
| – | – |
2025 Q3
1 quarter
|
|
4927
Innovator US Equity Accelerated 9 Buffer ETF July
XBJL
$77.2M
| $2.26K | ﹤0.01% |
59
-2,464
| -98% | -$92.9K |
2025 Q3
1 quarter
|
|
|
GLXY
4928
CALL
Galaxy Digital Inc
GLXY
$4.48B
| $2.24K | ﹤0.01% |
+100
| New | +$3.1K |
2025 Q4
0 quarters
|
|
4929
FTC Solar
FTCI
$35.5M
| $2.19K | ﹤0.01% |
201
+200
| +20,000% | +$1.82K |
2022 Q1
15 quarters
|
|
4930
Innovator US Equity Accelerated 9 Buffer ETF October
XBOC
$64M
| $2.11K | ﹤0.01% |
63
-5,761
| -99% | -$191K |
2024 Q3
5 quarters
|
|
|
NYAX
4931
Nayax
NYAX
$1.83B
| $2.08K | ﹤0.01% |
41
-852
| -95% | -$38.5K |
2022 Q4
12 quarters
|
|
4932
FT Vest US Equity Buffer ETF January
FJAN
$1.49B
| $2.07K | ﹤0.01% |
40
-2,078
| -98% | -$105K |
2024 Q3
5 quarters
|
|
4933
iShares MSCI South Africa ETF
EZA
$474M
| $2.06K | ﹤0.01% |
30
| – | – |
2022 Q1
15 quarters
|
|
4934
Ituran Location and Control
ITRN
$1.04B
| $2.06K | ﹤0.01% |
48
| – | – |
2022 Q4
12 quarters
|
|
4935
Kornit Digital
KRNT
$751M
| $2.06K | ﹤0.01% |
143
| – | – |
2020 Q2
22 quarters
|
|
|
ZAPR
4936
Innovator Equity Defined Protection ETF - 1 Yr April
ZAPR
$67.7M
| $2.04K | ﹤0.01% |
+79
| New | +$2.02K |
2025 Q4
0 quarters
|
|
4937
FT Vest US Equity Moderate Buffer ETF November
GNOV
$299M
| $2.03K | ﹤0.01% |
51
-5,222
| -99% | -$203K |
2025 Q1
3 quarters
|
|
4938
Innovator US Equity Ultra Buffer ETF July
UJUL
$302M
| $2.02K | ﹤0.01% |
52
-23
| -31% | -$882 |
2025 Q3
1 quarter
|
|
4939
FT Vest US Equity Deep Buffer ETF April
DAPR
$324M
| $2.01K | ﹤0.01% |
51
-3,515
| -99% | -$137K |
2024 Q3
5 quarters
|
|
4940
AllianzIM U.S. Equity Buffer10 Oct ETF
OCTT
$58.5M
| $2K | ﹤0.01% |
+46
| New | +$1.98K |
2025 Q4
0 quarters
|
|
|
EHLD
4941
Euroholdings Ltd
EHLD
$33.3M
| $1.97K | ﹤0.01% |
290
| – | – |
2025 Q1
3 quarters
|
|
4942
Greystone Housing Impact Investors LP
GHI
$130M
| $1.92K | ﹤0.01% |
278
+150
| +117% | +$1.17K |
2024 Q4
4 quarters
|
|
4943
Alpha Pro Tech
APT
$51.9M
| $1.89K | ﹤0.01% |
426
-12
| -3% | -$55 |
2024 Q3
5 quarters
|
|
4944
Transportadora de Gas del Sur
TGS
$3.77B
| $1.86K | ﹤0.01% |
+60
| New | +$1.7K |
2025 Q4
0 quarters
|
|
4945
Grupo Aeroportuario Centro Norte
OMAB
$4.55B
| $1.85K | ﹤0.01% |
17
-1,753
| -99% | -$183K |
2025 Q2
2 quarters
|
|
4946
Cue Biopharma
CUE
$186M
| $1.84K | ﹤0.01% |
201
| – | – |
2019 Q1
27 quarters
|
|
4947
iShares MSCI United Kingdom ETF
EWU
$3.58B
| $1.76K | ﹤0.01% |
40
| – | – |
2013 Q2
50 quarters
|
|
4948
XBP Global Holdings
XBP
$44.9M
| $1.7K | ﹤0.01% |
250
+156
| +166% | +$951 |
2025 Q3
1 quarter
|
|
|
KCHVU
4949
Kochav Defense Acquisition Corp Units
KCHVU
| $1.6K | ﹤0.01% |
155
| – | – |
2025 Q3
1 quarter
|
|
4950
AiRWA Inc
YYAI
$4.72M
| $1.56K | ﹤0.01% |
+3
| New | +$23K |
2025 Q4
0 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.